GovWhitePapers Logo

Sorry, your browser is not compatible with this application. Please use the latest version of Google Chrome, Mozilla Firefox, Microsoft Edge or Safari.

Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic

The coronavirus disease 2019 (COVID-19) pandemic has been associated with mental health challenges related to the morbidity and mortality caused by the disease and to mitigation activities, including the impact of physical distancing and stay-at-home orders. Symptoms of anxiety disorder and depressive disorder increased considerably in the United States during April–June of 2020, compared with the same period in 2019. To assess mental health, substance use, and suicidal ideation during the pandemic, representative panel surveys were conducted among adults aged ≥18 years across the United States during June 24–30, 2020.

 

Interested in healthcare? Check out this GovWhitePapers blog post! You can also find healthcare events on our sister site, GovEvents.

 

  • Author(s):
  • Mark É. Czeisler
  • Rashon I. Lane
  • Emiko Petrosky
  • Joshua F. Wiley
  • Aleta Christensen
  • Rashid Njai
  • Matthew D. Weaver
  • Rebecca Robbins
  • Rebecca Robbins
  • Laura K. Barger
  • Charles A. Czeisler
  • Mark E. Howard
  • Shantha M.W. Rajaratnam
  • Share this:
  • Share on Facebook
  • Share on Twitter
  • Share via Email
  • Share on LinkedIn
Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic
Format:
  • White Paper
Topics:
Website:Visit Publisher Website
Publisher:Centers for Disease Control and Prevention (CDC)
Published:August 14, 2020
License:Public Domain

Featured Content

Contact Publisher

Claim Content